 |
BioWorld-Insight-2010-08-23
New Data Help PhytoCeutica Push Botanical Drug Pathway
Sirtris Scandal Aside, Drugs Face No Supplemental Threat
The biotech industry was abuzz last week with the news that Christoph Westphal and Michelle Dipp – who sold resveratrol-based Sirtris Pharmaceuticals Inc. to GlaxoSmithKline plc for $720 million – were exposed for selling resveratrol online. (BioWorld Insight)
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: July 1 – Aug. 19, 2010
No Abstract